-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Inflammatory bowel disease (IBD), consisting of Crohn's disease (CD) and ulcerative colitis (UC), is an immune-mediated disease
The risk of VTE is significantly higher in patients with IBD, which is further increased
The researchers assessed the temporal trend of VTE in IBD using a nationwide sample of hospitalized patients from 2000-2018 in conjunction with the National Cancer Institute regression program, and the estimates were expressed as mean annual percentage change (AAPC) with a 95% confidence interval (CI
The findings show that between 2000 and 2018, 4859728 of IBD patients were hospitalized, of which 128236 (2.
This study confirms that VTE-related hospitalizations are increasing in patients with IBD, so this underscores the need for continued efforts
Original Source:
Adam S.